Reported Jul 30, 2025 · Ongoing

Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured…

Cipla USA, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Cipla USA, Inc. · 10 Independence Blvd · Warren, NJ · 07059-2730

Is this the product you have?

  • Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only
  • Manufactured byCipla Ltd. Indore SEZ, Pithampur, India
  • Manufactured for
    • Ciple USA
    • Inc. 10 Independence Boulevard
    • Suite 300
    • Warren
    • NJ 07059. NDC# 69097-319-86 (pouch)
    • 69097-319-87 (carton)
Lot codes and dates
    • Batch # 4IA0505
    • Exp 09/31/2026
Amount recalled
13,680 ampoules

Where it was sold

  • Nationwide

Why it was recalled

Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Cipla USA, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:06 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.